热点情报 食蟹猴价格暴涨近2倍 CRO（医药研发外包）企业核心生物资源之一的实验猴价格迎来暴涨！据北京商报，目前3—5岁左右的食蟹猴（实验猴的一种）价格已从最低5万元一只 涨至14万元一只，涨幅接近2倍，且年内已出现供不应求的局面。 比如，华盛锂电借VC添加剂涨价风口，股价47元一度大涨至155元。 如今，作为医学研究不可缺少的实验猴价格迎来暴涨，想必主力也不会错过机会。 为此，越声理财团队经过深度复盘，挖掘了4家核心公司。 其中一家，是国内实验猴资源最多的CRO企业之一，实验猴资源对其业绩影响显著。 前段时间，不仅被社保基金新进670万股，还被知名机构新进超过1900多万股。 所有人必须清楚，涨价题材向来是主力眼中的香饽饽。 比如，香农芯创凭存储芯片价格大涨，股价从40元飙升至204元。 ETF规模年内涨逾2万亿元 年内，ETF市场延续扩容态势，资金持续流入推动整体规模稳步抬升。数据显示，截至12月12日，今年以来全市场ETF规模增量已超过2万亿元，在权 益、债券、商品及跨境资产等多个方向均有体现，ETF作为重要资产配置工具的吸引力不断增强。 12月15日，龙洲股份逆势大涨9.95%，收盘价11.93元，成 ...

Core Insights - The exchange-traded fund (ETF) market has experienced accelerated expansion in 2023, with total assets surpassing 5 trillion yuan as of August 25 [1] - As of September 4, the total market size of ETFs reached 5.02 trillion yuan [1] Summary by Category - **Market Growth** - The ETF market has shown significant growth this year, indicating a robust interest from investors [1] - The milestone of 5 trillion yuan was achieved on August 25, highlighting a key moment in the market's expansion [1] - **Current Market Size** - The total market size of ETFs reached 5.02 trillion yuan as of September 4, reflecting ongoing growth trends [1]

Group 1 - The total scale of ETFs has reached 4.16 trillion yuan as of June 9, 2023, with an increase of nearly 440 billion yuan this year and a total of 2.74 trillion shares, indicating widespread recognition and application of ETFs as financial instruments [1] - There are 14 ETFs that have added over 10 billion yuan in scale this year, with the highest single product adding over 30 billion yuan, primarily in stock and commodity funds, particularly in gold-themed and broad-based products [1] - The performance of innovative drug companies has improved, leading to a general increase in the net value growth rate of related thematic funds, with many funds showing growth rates above 40% [2][3] Group 2 - The international trade situation presents significant uncertainties, which may increase the demand for gold assets, especially as the dollar is at its lowest level in three years, potentially supporting gold prices [2] - A total of 136 new ETFs have been issued this year, bringing the total to 1,191, with the materials sector seeing the largest increase in shares, and the China Innovation Drug Industry Index being the most tracked theme [2] - The innovative drug sector has experienced a strong market performance due to multiple favorable factors, including improved sentiment and significant capital inflows, marking a transition into a harvest period for innovative drug companies [3]